Details of the Drug | DrugMAP

General Information of Drug (ID: DM1TH08)

Drug Name	Ferricyanide
Synonyms	Ferric hexacyanide; Ferricyanide; Hexacyanoferrate(III); Hexazyanoferrat(III); hexacyanidoferrate(3-); hexacyanidoferrate(III); hexacyanoferrate III; hexacyanoferrate(3-); hexacyanoiron(3-); 13408-62-3; CHEBI:5020; CRWNKXHVYMVLCY-UHFFFAOYSA-N; [Fe(CN)6](3-)
Structure
Structure	3D MOL is unavailable			2D MOL
#Ro5 Violations (Lipinski): 1	Molecular Weight			211.95
	Logarithm of the Partition Coefficient			Not Available
	Rotatable Bond Count			0
	Hydrogen Bond Donor Count			0
	Hydrogen Bond Acceptor Count			12
Chemical Identifiers	Formula C6FeN6-3 IUPAC Name iron(3+);hexacyanide Canonical SMILES [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+3] InChI YAGKRVSRTSUGEY-UHFFFAOYSA-N InChIKey 1S/6CN.Fe/c61-2;/q6-1;+3
Cross-matching ID	PubChem CID 439210 ChEBI ID CHEBI:5020 CAS Number 13408-62-3 INTEDE ID DR2046

Molecular Interaction Atlas of This Drug

Drug-Metabolizing Enzyme (DME)

DME Name	DME ID	UniProt ID	MOA	REF
Methionine synthase reductase (MTRR)	DE6NIY9	MTRR_HUMAN	Substrate	[1]
Diaphorase-1 (CYB5R3)	DE4A3BL	NB5R3_HUMAN	Substrate	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2002 Nov 12;41(45):13378-85.
2	Expression of a novel P275L variant of NADH:cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide binding. Arch Biochem Biophys. 2006 Mar 1;447(1):59-67.